Prediction of pulmonary complications after a lobectomy in patients with non-small cell lung cancer

Thorax. 2001 Jan;56(1):59-61. doi: 10.1136/thorax.56.1.59.

Abstract

Background: Although the preoperative prediction of pulmonary complications after lung major surgery has been reported in various papers, it still remains unclear.

Methods: Eighty nine patients with stage I-IIIA non-small cell lung cancer (NSCLC) who underwent a complete resection at our institute from 1994-8 were evaluated for the feasibility of making a preoperative prediction of pulmonary complications. All had either a predicted postoperative forced vital capacity (FVC) of >800 ml/m(2) or forced expiratory volume in one second (FEV(1)) of >600 ml/m(2).

Results: Postoperative complications occurred in 37 patients (41.2%) but no patients died during the 30 day period after the operation. Pulmonary complications occurred in 20 patients (22.5%). Univariate analysis indicated that the factors significantly related to pulmonary complications were FVC <80%, serum lactate dehydrogenase (LDH) level > or =230 U/l, and arterial oxygen tension (PaO(2)) <10.6 kPa (80 mm Hg). In a multivariate analysis the three independent predictors of pulmonary complications were serum LDH > or =230 U/l (odds ratio (OR) 10.5, 95% CI 1.4 to 77.3), residual volume (RV)/total lung capacity (TLC) > or =30% (OR 6.0, 95% CI 1.1 to 33.7), and PaO(2) <10.6 kPa (OR 5.6, 95% CI 1.4 to 22.2).

Conclusions: The above findings indicate that three factors (serum LDH levels of > or =230 U/l, RV/TLC > or =30%, and PaO(2) <10.6 kPa) may be associated with pulmonary complications in patients undergoing a lobectomy for NSCLC, even though the patient group was relatively small for statistical analysis of such a diverse subject as pulmonary complications.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Analysis of Variance
  • Biomarkers / blood
  • Bronchoscopy
  • Carcinoma, Non-Small-Cell Lung / blood
  • Carcinoma, Non-Small-Cell Lung / physiopathology
  • Carcinoma, Non-Small-Cell Lung / surgery*
  • Feasibility Studies
  • Female
  • Forced Expiratory Volume / physiology
  • Humans
  • L-Lactate Dehydrogenase / blood
  • Lung Neoplasms / blood
  • Lung Neoplasms / physiopathology
  • Lung Neoplasms / surgery*
  • Male
  • Middle Aged
  • Morbidity
  • Oxygen / blood
  • Postoperative Complications / diagnosis*
  • Prognosis
  • Respiration Disorders / physiopathology
  • Treatment Outcome
  • Vital Capacity / physiology

Substances

  • Biomarkers
  • L-Lactate Dehydrogenase
  • Oxygen